Carbamazepine Capsule, Extended Release shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting Dec 19, 2025 · last update Dec 19, 2025
Manufacturers: Takeda Pharmaceuticals USA Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 19, 2025 Updated Dec 19, 2025 Discontinued Dec 19, 2025 |
| Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 19, 2025 Updated Dec 19, 2025 Discontinued Dec 19, 2025 |
| Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12) | Takeda Pharmaceuticals USA Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 19, 2025 Updated Dec 19, 2025 Discontinued Dec 19, 2025 |